HopeStage
Back to overview

Schizophrenia studies

Topics
More filters

Schizophrenia

Schizophrenia can affect how a person perceives reality, thinks and feels, sometimes involving hearing voices or holding unusual beliefs.

4505studies shown
Showing 1,537-1,548 of 4,505
Other study type icon
CompletedNCT02921243

Schizophrenia and the Gut Microbiome

This study has finished and is no longer accepting participants.

In Catonsville
SchizophreniaObservational studyAges 18–64
Countries
United States
Sponsor
University of Maryland, Baltimore
Other study type icon
CompletedNCT01001481

Schizophrenia Treatment Adherence Investigation (STAI)

Official study title

Clinical Audit and Feedback Program to Determine Risk for Medication Adherence in Outpatients Diagnosed With Schizophrenia in Australia

This study has finished and is no longer accepting participants.

Location not clearly listed
SchizophreniaObservational studyAges 18+
Countries
Sponsor
Janssen-Cilag Pty Ltd
Drug study icon
CompletedNCT02567370

Single-ascending Dose Study With a Food-Effect Cohort to Evaluate AMG 581

Official study title

A Phase 1, Randomized, Double-blind, Placebo-controlled, Single-ascending Dose Study With a Food-Effect Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 581 in Healthy Subjects and Subjects With Schizophrenia

This study has finished and is no longer accepting participants.

In Glendale
SchizophreniaMedication studyAges 18–45
Countries
United States
Sponsor
Amgen
Drug study icon
CompletedNCT00320697

Smoking Relapse Prevention in Schizophrenia

Official study title

A Trial of the Effects of Bupropion, Nicotine Replacement Therapy and CBT on Smoking Cessation and Smoking Relapse in Patients With Schizophrenia

This study has finished and is no longer accepting participants.

In Boston
SchizophreniaMedication studyAges 18–70
Countries
United States
Sponsor
North Suffolk Mental Health Association
Drug study icon
CompletedNCT05859698

Effectiveness of valbenazine in adults with tardive dyskinesia

Official study title

A Phase 4, Single-Arm, Open-Label Study to Evaluate the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Subjects With Tardive Dyskinesia

This study has finished and is no longer accepting participants.

Multiple locations, including Bryant
Schizophrenia, Depression, ...Medication studyAges 18+
Countries
United States
Sponsor
Neurocrine Biosciences (Biotech company)
Drug study icon
CompletedNCT02810964

Sulforaphane to Reduce Symptoms of Schizophrenia

What is this study about?

Researchers compared Sulforaphane Nutraceutical and placebo to find out how the approaches affected psychotic symptoms in people with schizophrenia.

This study has finished and is no longer accepting participants.

In Towson
SchizophreniaMedication studyAges 18–65
Countries
United States
Sponsor
Sheppard Pratt Health System

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.